Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to -$101000.0.

  • Utah Medical Products' Change in Inventory fell 5074.63% to -$101000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 4259.5%. This contributed to the annual value of -$587000.0 for FY2024, which is 18761.19% down from last year.
  • Per Utah Medical Products' latest filing, its Change in Inventory stood at -$101000.0 for Q3 2025, which was down 5074.63% from -$633000.0 recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Change in Inventory registered a high of $1.1 million during Q3 2022, and its lowest value of -$633000.0 during Q2 2025.
  • In the last 5 years, Utah Medical Products' Change in Inventory had a median value of -$67000.0 in 2024 and averaged $100631.6.
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 49082.13% in 2022, then tumbled by 27235.29% in 2025.
  • Quarter analysis of 5 years shows Utah Medical Products' Change in Inventory stood at $324000.0 in 2021, then dropped by 11.11% to $288000.0 in 2022, then plummeted by 188.54% to -$255000.0 in 2023, then surged by 69.02% to -$79000.0 in 2024, then fell by 27.85% to -$101000.0 in 2025.
  • Its Change in Inventory was -$101000.0 in Q3 2025, compared to -$633000.0 in Q2 2025 and -$275000.0 in Q1 2025.